Understanding Changes in Heart Function After Exercise in People With Stroke
Beyond VO2peak: Understanding Exercise-induced Changes in Cardiovascular Function After Stroke
1 other identifier
interventional
60
1 country
2
Brief Summary
Little is known about how exercise can affect heart function in stroke survivors. This study will look at changes in cardiovascular fitness and function after 6 months of exercise. Volunteers will be tested before and after the program and again 2 months later to measure the effects on stroke risk factors, fitness level and flexibility of the arteries. Blood tests will measure cholesterol levels and other signs of inflammation. This study will help us better understand how exercise after stroke can improve heart function and heart health, and ultimately help in lowering future stroke risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Sep 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2010
CompletedFirst Posted
Study publicly available on registry
August 26, 2010
CompletedStudy Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedMay 10, 2017
May 1, 2017
1.1 years
August 24, 2010
May 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stroke risk factors (blood pressure, heart rate, lipid profiles, glucose metabolism), cardiorespiratory fitness
assessed at baseline (0 months), post-program (6 months) and follow up (8 months)
Secondary Outcomes (3)
Arterial stiffness and inflammatory biomarkers
assessed at 0, 6 and 8 months
Echocardiography measures
assessed at 0 and 6 months
Ambulatory capacity and health related quality of life
assessed at 0, 6 and 8 months
Study Arms (2)
Aerobic Program
EXPERIMENTALThe Aerobic Program will be the Experimental arm of this trial, where a structured, progressive aerobic exercise will be conducted in a class format
Balance and Flexibility Program
ACTIVE COMPARATORThe Balance and Flexibility Program will be a non-aerobic intervention that will act as an Active Comparator. Stretching, balance exercises, yoga- or Tai Chi-style classes will be conducted.
Interventions
The AEROBIC PROGRAM will be the Experimental arm of this trial. It will be a structured, progressive aerobic training program that will be 6 months in duration. Classes will be held 3 times / week, for 1 hour / session.
The BALANCE AND FLEXIBILITY (non-aerobic) PROGRAM will be the Active Comparator arm of this trial. It will be comprised of upper and lower body stretching, or balance activities, yoga- or Tai Chi-style classes. This program will be 6 months in duration. Classes will be held 3 times / week, for 1 hour / session.
Eligibility Criteria
You may qualify if:
- Age 50-80 years old
- Has experienced a stroke
- At least 12 months post-stroke
- Able to stand independently
- Able to walk at least 5 metres (assisted devices and guarded supervision is permitted)
You may not qualify if:
- Stroke of non-cardiogenic origin (aneurysm, tumour)
- Actively engaged in other stroke rehabilitation services
- Class C or D American Heart Association Risk Criteria (uncontrolled arrhythmias)
- Resting blood pressure \> 160/100 mmHg
- Significant musculoskeletal problems (rheumatoid arthritis) or other neurological conditions (e.g. Parkinson's)
- Has a pacemaker
- Pain or other co-morbidities (e.g. unclipped aneurysms, uncontrolled seizures etc.) which would preclude participation
- Behavioural issues that would limit participation in exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
GF Strong Rehabilitation Centre
Vancouver, British Columbia, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janice Eng, PhD
The University of British Columbia - Vancouver Coastal Health Research Institute
- STUDY DIRECTOR
Penelope Brasher, PhD
Vancover General Hospital
- STUDY DIRECTOR
Andrei Krassioukov, MD, PhD
University of British Columbia
- STUDY DIRECTOR
Kenneth Madden, MD
University of British Columbia
- STUDY DIRECTOR
Ada Tang
University of British Columbia
- STUDY DIRECTOR
Teresa Tsang, MD
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 24, 2010
First Posted
August 26, 2010
Study Start
September 1, 2010
Primary Completion
October 1, 2011
Study Completion
April 1, 2012
Last Updated
May 10, 2017
Record last verified: 2017-05